Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Has Iran Won the War? It Thinks So Update By Howard Bloom

    May 29, 2026

    Bret Michaels Bails on Trump’s Great American State Fair

    May 29, 2026

    Girls Who Code CEO: 70% of teen girls want to work in cybersecurity. We’re losing them before they start

    May 29, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Science»Paxlovid: Covid-19 rebound seen in some people after taking the Pfizer drug
    Science

    Paxlovid: Covid-19 rebound seen in some people after taking the Pfizer drug

    By AdminMay 18, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Paxlovid: Covid-19 rebound seen in some people after taking the Pfizer drug


    Pfizer’s Paxlovid can prevent severe covid-19 in vulnerable people when taken as a five-day course at home, but the medicine may not eradicate the virus in everyone



    Health



    18 May 2022

    By Clare Wilson

    The Pfizer medicine Paxlovid can protect against severe covid-19 in vulnerable people

    The Pfizer medicine Paxlovid can protect against severe covid-19 in vulnerable people

    Fabian Sommer/dpa/Alamy

    One of the most effective medicines against severe covid-19 may not eradicate the virus in everyone. Several countries – including the US, UK, Canada, Israel and France – may prescribe a five-day course of the Pfizer drug Paxlovid, which can be taken at home, to people who are particularly vulnerable to covid-19’s complications.

    In the trial that led to its approval, Paxlovid cut the risk of a covid-19-related hospitalisation or death by 88 per cent. But emerging reports now suggest …



    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleClassical/Rock Violinist Daisy Jopling Guests On The Mike Wagner Show on iHeart Radio
    Next Article Polymega SEGA Dreamcast Support Could be Coming Soon to the Modular Game Console

    RELATED POSTS

    White House proposes new rules giving political appointees final approval on research grants

    May 29, 2026

    Mathematical AI helps researchers crack 50-year-old problem

    May 29, 2026

    These Ebola Researchers Are Stuck in US Due to Trump’s Funding Cuts

    May 28, 2026

    A quantum computing system’s perfect randomness could keep your secrets safe

    May 28, 2026

    We may finally know why gold stays so shiny

    May 27, 2026

    The Cookware Industry Has a Major Fight Brewing Over PFAS Claims

    May 27, 2026
    latest posts

    Has Iran Won the War? It Thinks So Update By Howard Bloom

    Our president believes we’ve won the Iran war. He might be surprised to discover that…

    Bret Michaels Bails on Trump’s Great American State Fair

    May 29, 2026

    Girls Who Code CEO: 70% of teen girls want to work in cybersecurity. We’re losing them before they start

    May 29, 2026

    Power To The People Protest Festival Will Be The Final Pre-Midterm Nail In Trump’s Coffin

    May 29, 2026

    Archaeologists discover 2,500-year-old Bronze Age neck rings in Swedish grave

    May 29, 2026

    This chip startup just raised $135M on a bet that AI’s biggest bottleneck isn’t compute — it’s memory

    May 29, 2026

    White House proposes new rules giving political appointees final approval on research grants

    May 29, 2026
    Categories
    • Books (1,272)
    • Business (6,176)
    • Events (55)
    • Film (6,113)
    • Lifestyle (4,210)
    • Music (6,231)
    • Politics (6,171)
    • Science (5,530)
    • Technology (6,109)
    • Television (5,796)
    • Uncategorized (7)
    • US News (6,164)
    popular posts

    NBA champ Andrew Wiggins talks winning culture in Golden State, Klay Thompson’s return and latest partnership

    NEWYou can now listen to Fox News articles! There’s a tendency in sports to expect…

    Tushy, Nordstrom Rack and Nutribullet: Best online sales right now

    July 21, 2022

    UK scaleups should HMRC-proof their business plans before a slow, hot summer – TechCrunch

    June 20, 2022

    Dry Cleaning Share Video for New Song “Cruise Ship Designer”: Watch

    November 12, 2025
    Archives
    Browse By Category
    • Books (1,272)
    • Business (6,176)
    • Events (55)
    • Film (6,113)
    • Lifestyle (4,210)
    • Music (6,231)
    • Politics (6,171)
    • Science (5,530)
    • Technology (6,109)
    • Television (5,796)
    • Uncategorized (7)
    • US News (6,164)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    This chip startup just raised $135M on a bet that AI’s biggest bottleneck isn’t compute — it’s memory

    May 29, 2026

    White House proposes new rules giving political appointees final approval on research grants

    May 29, 2026

    GTA 6 Unreal Loading Times Shown In Leaked Gameplay

    May 29, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT